Prediction of chronic neonatal lung disease in very low birthweight neonates using clinical and radiological variables.

Archives of Disease in Childhood: Fetal and Neonatal Edition - Tập 71 Số 1 - Trang F36-F39 - 1994
Steven Ryan1, N J Wild1, Rosemary Arthur1, Brian Shaw1
1University Department of Neonatal Medicine, Liverpool Maternity Hospital.

Tóm tắt

There are good theoretical reasons for earlier intervention in neonates likely to develop chronic neonatal lung disease (CNLD). Very low birthweight (VLBW) neonates who receive artificial ventilation are at high risk of CNLD. A test was therefore developed to predict CNLD based on clinical and radiological information readily available at 7 days of age in VLBW neonates. Logistic regression analysis was used to identify those factors significantly and independently associated with CNLD. For each neonate it was possible to insert the value of the independent factors into the equation, providing a probability value between 0 and 1. By selecting different cut off values between 0 and 1, and knowing which neonates had developed CNLD, it was possible to assess the use of varying probability values as a predictive test for CNLD. The variation in these two parameters was graphically represented by a receiver operator characteristic (ROC) curve. The area under the ROC curve was used to represent the discriminatory capacity of the test over its full range of values. The maximum area under an ROC curve is unity. The area under the ROC curve was similar in a model with and without radiographic information (0.926 and 0.913 respectively) and was 0.937 in neonates from another hospital.

Từ khóa


Tài liệu tham khảo

Osiris collaborative group. Early versus delayed neonatal administration of a synthetic surfactant - the judgement of OSIRIS. Lancet 1992; ii: 1363-9.

Collaborative dexamethasone trial group. Dexamethasone therapy in neonatal chronic lung disease; an international placebo controlled trial. Pediatrics 1991; 88: 421-7.

Merrit TA, Cochrane CG, Holcomb K, et al. Elastase and alpha-I proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome; role in the pathogenesis of bronchopulmonary of inflammation dysplasia..7 Clin Invest 1983; 72: 656-6.

Ng PC. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 1993; 68: 330-6.

Cooke RWI. Factors associated with periventricular haemorrhage in very low birthweight infants. Arch Dis Child 1981; 56: 425-31.

Northway WH. Bronchopulmonary dysplasia: then and now. Arch Dis Chdd 1990; 65: 1076-81.

Moylan FMB, Walker AM, Kramer SS, Todrens ID, Shannon DC. Alveolar rupture as an independent predictor of broncho-pulmonary dysplasia. Crit Care Med 1978; 6: 10-3.

Swischuk LE. Bubbles in hyaline membrane disease: differentiation into three types. Radiology 1977; 122: 417-26.

Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator bronchopulmonary therapy of dysplasia. hyaline N Engl membrane disease; J Med 1967; 276: 357-8.

Beck A, Schultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986; 110: 13-25.

Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic curve. Radiology 1982; 143: 29-36.

Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.

Russell GAB, Smyth A, Cooke RWI. Receiver operator characteristic curves for comparison of serial neutrophil band forms and C reactive protein in neonates at risk of infection. Arch Dis Child 1992; 67: 808-12.

Cooke R, Ryan S, Walkinshaw S. Steroids for babies. Lancet 1993; i: 569.

Thông tin
Thông tin xuất bản

Archives of Disease in Childhood: Fetal and Neonatal Edition

Tập 71 Số 1

F36-F39

Thông tin tác giả